Abstract
The fibulins are a group of glycoproteins that function predominantly though not exclusively in the extracellular matrix (ECM). In common with the fibrillins and hemicentins, which are also ECM protein families, their basic characteristic is an FC (fibulin-type) unit at the protein C-terminal preceded by an array of adjoining cbEGF (Ca++ binding epidermal growth factor-like) modules of varying number. They may have up to four protein domains (N, I, II, III) and can be subdivided into two main subgroups (1 and 2) (Timpl et al., Nat Rev Mol Cell Biol 4(6):479–489, 2003). Subgroup 1, which contains fibulin-1 and fibulin-2, has the largest molecules (Table 9.1). Fibulin-1 can have up to three protein domains but fibulin-2 is unique in also containing a large N domain preceding domain I at the N terminus of the protein. Subgroup 2 contains fibulin-3, fibulin-4 and fibulin-5 and these have three domains, one of which is very small. These complete molecules are much smaller than either of those in subgroup 1. The new fibulins, fibulin-6 and fibulin-7 are only being characterized presently.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albig AR, Schiemann WP (2004) Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol 23(6):367–379
Argraves WS, Dickerson K et al (1989) Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain. Cell 58(4):623–629
Chaudhry SS, Gazzard J et al (2001) Mutation of the gene encoding fibrillin-2 results in syndactyly in mice. Hum Mol Genet 10(8):835–843
Chu ML, Tsuda T (2004) Fibulins in development and heritable disease. Birth Defects Res C Embryo Today 72(1):25–36
Cohen S, Elliott GA (1989) The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse. 1962. J Invest Dermatol 92(Suppl 4):157S; discussion 158S–159S
Dameron KM, Volpert OV et al (1994) The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harb Symp Quant Biol 59:483–489
de Vega S, Iwamoto T et al (2007) TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding. J Biol Chem 282(42):30878–88
de Vega S, Iwamoto T et al (2009) Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 66(11–12):1890–1902
Downing AK, Knott V et al (1996) Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 85(4):597–605
Gallagher WM, Argentini M et al (1999) MBP1: a novel mutant p53-specific protein partner with oncogenic properties. Oncogene 18(24):3608–3616
Gallagher WM, Greene LM et al (2001) Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissues. FEBS Lett 489(1):59–66
Gallagher WM, Currid CA et al (2005) Fibulins and cancer: friend or foe? Trends Mol Med 11(7):336–340
Giltay R, Timpl R et al (1999) Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4. Matrix Biol 18(5):469–480
Greene LM, Twal WO et al (2003) Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br J Cancer 88(6):871–878
Hu Q, Loeys BL et al (2006) Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa. Hum Mol Genet 15(23):3379–3386
Huber R, Scholze H et al (1980) Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppe Seylers Z Physiol Chem 361(9):1389–1399
Hubmacher D, El-Hallous EI et al (2008) Biogenesis of extracellular microfibrils: multimerization of the fibrillin-1 C terminus into bead-like structures enables self-assembly. Proc Natl Acad Sci U S A 105(18):6548–6553
Hucthagowder V, Sausgruber N et al (2006) Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet 78(6):1075–1080
Hugli TE et al (1986) Biochemistry and biology of anaphylatoxins. Complement 3(3):111–127
Kieser A, Weich HA et al (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9(3):963–969
Kobayashi N, Kostka G et al (2007) A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem 282(16):11805–11816
Loeys B, Van Maldergem L et al (2002) Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 11(18):2113–2118
Marmorstein LY, Munier FL et al (2002) Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad Sci U S A 99(20):13067–13072
Moll F, Katsaros D et al (2002) Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 21(7):1097–1107
Mukhopadhyay D, Tsiokas L et al (1995) Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55(24):6161–6165
Pan TC, Kluge M et al (1993) Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands. Eur J Biochem 215(3):733–740
Qing J, Maher VM et al (1997) Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 15(18):2159–2168
Reinhardt DP, Sasaki T et al (1996) Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J Biol Chem 271(32):19489–19496
Roger P, Pujol P et al (1998) Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors. Am J Pathol 153(5):1579–1588
Sasaki T, Mann K et al (1997) Dimer model for the microfibrillar protein fibulin-2 and identification of the connecting disulfide bridge. EMBO J 16(11):3035–3043
Savage CR Jr, Inagami T et al (1972) The primary structure of epidermal growth factor. J Biol Chem 247(23):7612–7621
Schiemann WP, Blobe GC et al (2002) Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem 277(30):27367–27377
Schultz DW, Klein ML et al (2003) Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 12(24):3315–3323
Sisto M, D’Amore M et al (2009) Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren’s syndrome. Int Immunol 21(3):303–311
Spencer JA, Hacker SL et al (2005) Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci U S A 102(8):2946–2951
Stone EM, Lotery AJ et al (1999) A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22(2):199–202
Tarttelin EE, Gregory-Evans CY et al (2001) Molecular genetic heterogeneity in autosomal dominant drusen. J Med Genet 38(6):381–384
Timpl R, Sasaki T et al (2003) Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4(6):479–489
Twal WO, Czirok A et al (2001) Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 114(Pt 24):4587–4598
Wlazlinski A, Engers R et al (2007) Downregulation of several fibulin genes in prostate cancer. Prostate 67(16):1770–1780
Wu YS, Bevilacqua VL et al (1995) Fibrillin domain folding and calcium binding: significance to Marfan syndrome. Chem Biol 2(2):91–97
Xie L, Palmsten K et al (2008) Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Exp Biol Med (Maywood) 233(2):155–162
Xu X, Dong C et al (2007) Hemicentins assemble on diverse epithelia in the mouse. J Histochem Cytochem 55(2):119–126
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Cooney, H.C., Gallagher, W.M. (2011). Fibulins and Their Role in the ECM. In: Mueller, M., Fusenig, N. (eds) Tumor-Associated Fibroblasts and their Matrix. The Tumor Microenvironment, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0659-0_9
Download citation
DOI: https://doi.org/10.1007/978-94-007-0659-0_9
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0658-3
Online ISBN: 978-94-007-0659-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)